Zeng, Ying-Xuan
Chou, Kuang-Yi
Hwang, Jeng-Jong
Wang, Hwai-Shi
Funding for this research was provided by:
National Science and Technology Council (MOST 110-2320-B-A49A-516)
Article History
Received: 18 April 2023
Accepted: 27 June 2023
First Online: 30 June 2023
Competing interests
: The authors declare that a patent application entitled "Composition and Use of Interleukin Stimulated Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Rheumatoid Arthritis" granted in Taiwan in 26-July-2022 was part of the research in this paper. Based on part of the research in this paper, an US patent application of the same title was filed on 8-JUN-2021.